GSK3B and early-onset autosomal dominant Alzheimer disease: In an Alzheimer's disease research, it was revealed that estrogen receptor and GSK3B could change the tau protein phosphorylation, indicating sex involved in pathogenesis of this neurodegenerative disease [22].